United States · FDA National Drug Code directory

Darunavir 600 and 800 mg

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
69097-244_e3d4803e-30b2-4c8b-90e3-b04c2da4b1c9
Product NDC
69097-244
Form
TABLET
Composition / generic term
darunavir
Labeler
Cipla USA Inc.
Marketing category
ANDA
Marketing start / end (source format)
20231129
Source listing expiry
20261231

Source-listed ingredients

  • DARUNAVIR HYDRATE — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (69097-244-02) · 69097-244-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →